TY - CHAP
T1 - Special problems in cavernous malformations
T2 - Migraine, pregnancy, hormonal replacement, anticoagulation, NSAIDs, stress, and altitude elevation changes
AU - Leigh, Richard
AU - Wityk, Robert J.
N1 - Publisher Copyright:
© Cambridge University Press 2011.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Introduction Cerebral cavernous malformations (CCM) of the nervous system are relatively rare and can be symptomatic or incidentally discovered. Factors leading to their discovery are varied and not always causally associated. While a seizure may lead to discovery of a symptomatic CCM, a headache may lead to an incidental discovery of an asymptomatic CCM. Cerebrovascular neurologists and neurosurgeons are often asked about the safety and relationship of various medical issues with the CCM. The problem of epilepsy is covered in another chapter. In this chapter, we focus on some common questions that have arisen during consultation, such as the relationship to migraine, effects of pregnancy, and particularly the safety of use of antithrombotic agents in CCM patients. With the widespread use of brain MRI and the more frequent use of hemosiderin-sensitive sequences, the discovery of asymptomatic CCMs will probably increase. This book contains current information concerning the pathology, diagnosis and natural history and treatment of CCMs, but a number of medical and neurological issues arise in patients with CCMs that have not been as well studied. These issues will eventually present to the practitioner, and we have reviewed the literature to give the best guidance on management.
AB - Introduction Cerebral cavernous malformations (CCM) of the nervous system are relatively rare and can be symptomatic or incidentally discovered. Factors leading to their discovery are varied and not always causally associated. While a seizure may lead to discovery of a symptomatic CCM, a headache may lead to an incidental discovery of an asymptomatic CCM. Cerebrovascular neurologists and neurosurgeons are often asked about the safety and relationship of various medical issues with the CCM. The problem of epilepsy is covered in another chapter. In this chapter, we focus on some common questions that have arisen during consultation, such as the relationship to migraine, effects of pregnancy, and particularly the safety of use of antithrombotic agents in CCM patients. With the widespread use of brain MRI and the more frequent use of hemosiderin-sensitive sequences, the discovery of asymptomatic CCMs will probably increase. This book contains current information concerning the pathology, diagnosis and natural history and treatment of CCMs, but a number of medical and neurological issues arise in patients with CCMs that have not been as well studied. These issues will eventually present to the practitioner, and we have reviewed the literature to give the best guidance on management.
UR - http://www.scopus.com/inward/record.url?scp=84932170225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84932170225&partnerID=8YFLogxK
U2 - 10.1017/CBO9781139003636.020
DO - 10.1017/CBO9781139003636.020
M3 - Chapter
AN - SCOPUS:84932170225
SN - 9780521764278
SP - 185
EP - 190
BT - Cavernous Malformations of the Nervous System
PB - Cambridge University Press
ER -